TY - JOUR
T1 - Examining the impact of a 9-component bundle and the INICC multidimensional approach on catheter-associated urinary tract infection rates in 32 countries across Asia, Eastern Europe, Latin America, and the Middle East
AU - Rosenthal, Victor D.
AU - Yin, Ruijie
AU - Jin, Zhilin
AU - Perez, Valentina
AU - Kis, Matthew A.
AU - Abdulaziz-Alkhawaja, Safaa
AU - Valderrama-Beltran, Sandra L.
AU - Gomez, Katherine
AU - Rodas, Claudia M.H.
AU - El-Sisi, Amal
AU - Sahu, Suneeta
AU - Kharbanda, Mohit
AU - Rodrigues, Camilla
AU - Myatra, Sheila N.
AU - Chawla, Rajesh
AU - Sandhu, Kavita
AU - Mehta, Yatin
AU - Rajhans, Prasad
AU - Arjun, Rajalakshmi
AU - Tai, Chian Wern
AU - Bhakta, Arpita
AU - Mat Nor, Mohd Basri
AU - Aguirre-Avalos, Guadalupe
AU - Sassoe-Gonzalez, Alejandro
AU - Bat-Erdene, Ider
AU - Acharya, Subhash P.
AU - Aguilar-de-Moros, Daisy
AU - Carreazo, Nilton Yhuri
AU - Duszynska, Wieslawa
AU - Hlinkova, Sona
AU - Yildizdas, Dincer
AU - Kılıc, Esra K.
AU - Dursun, Oguz
AU - Odek, Caglar
AU - Deniz, Suna S.O.
AU - Guclu, Ertugrul
AU - Koksal, Iftihar
AU - Medeiros, Eduardo A.
AU - Petrov, Michael M.
AU - Tao, Lili
AU - Salgado, Estuardo
AU - Dueñas, Lourdes
AU - Daboor, Mohammad A.
AU - Raka, Lul
AU - Omar, Abeer A.
AU - Ikram, Aamer
AU - Horhat-Florin, George
AU - Memish, Ziad A.
AU - Brown, Eric C.
N1 - Publisher Copyright:
© 2024 Association for Professionals in Infection Control and Epidemiology, Inc.
PY - 2024/8
Y1 - 2024/8
N2 - Background: Catheter-Associated Urinary Tract Infections (CAUTIs) frequently occur in the intensive care unit (ICU) and are correlated with a significant burden. Methods: We implemented a strategy involving a 9-element bundle, education, surveillance of CAUTI rates and clinical outcomes, monitoring compliance with bundle components, feedback of CAUTI rates and performance feedback. This was executed in 299 ICUs across 32 low- and middle-income countries. The dependent variable was CAUTI per 1,000 UC days, assessed at baseline and throughout the intervention, in the second month, third month, 4 to 15 months, 16 to 27 months, and 28 to 39 months. Comparisons were made using a 2-sample t test, and the exposure-outcome relationship was explored using a generalized linear mixed model with a Poisson distribution. Results: Over the course of 978,364 patient days, 150,258 patients utilized 652,053 UC-days. The rates of CAUTI per 1,000 UC days were measured. The rates decreased from 14.89 during the baseline period to 5.51 in the second month (risk ratio [RR] = 0.37; 95% confidence interval [CI] = 0.34-0.39; P < .001), 3.79 in the third month (RR = 0.25; 95% CI = 0.23-0.28; P < .001), 2.98 in the 4 to 15 months (RR = 0.21; 95% CI = 0.18-0.22; P < .001), 1.86 in the 16 to 27 months (RR = 0.12; 95% CI = 0.11-0.14; P < .001), and 1.71 in the 28 to 39 months (RR = 0.11; 95% CI = 0.09-0.13; P < .001). Conclusions: Our intervention, without substantial costs or additional staffing, achieved an 89% reduction in CAUTI incidence in ICUs across 32 countries, demonstrating feasibility in ICUs of low- and middle-income countries.
AB - Background: Catheter-Associated Urinary Tract Infections (CAUTIs) frequently occur in the intensive care unit (ICU) and are correlated with a significant burden. Methods: We implemented a strategy involving a 9-element bundle, education, surveillance of CAUTI rates and clinical outcomes, monitoring compliance with bundle components, feedback of CAUTI rates and performance feedback. This was executed in 299 ICUs across 32 low- and middle-income countries. The dependent variable was CAUTI per 1,000 UC days, assessed at baseline and throughout the intervention, in the second month, third month, 4 to 15 months, 16 to 27 months, and 28 to 39 months. Comparisons were made using a 2-sample t test, and the exposure-outcome relationship was explored using a generalized linear mixed model with a Poisson distribution. Results: Over the course of 978,364 patient days, 150,258 patients utilized 652,053 UC-days. The rates of CAUTI per 1,000 UC days were measured. The rates decreased from 14.89 during the baseline period to 5.51 in the second month (risk ratio [RR] = 0.37; 95% confidence interval [CI] = 0.34-0.39; P < .001), 3.79 in the third month (RR = 0.25; 95% CI = 0.23-0.28; P < .001), 2.98 in the 4 to 15 months (RR = 0.21; 95% CI = 0.18-0.22; P < .001), 1.86 in the 16 to 27 months (RR = 0.12; 95% CI = 0.11-0.14; P < .001), and 1.71 in the 28 to 39 months (RR = 0.11; 95% CI = 0.09-0.13; P < .001). Conclusions: Our intervention, without substantial costs or additional staffing, achieved an 89% reduction in CAUTI incidence in ICUs across 32 countries, demonstrating feasibility in ICUs of low- and middle-income countries.
KW - Device-associated infection
KW - Health care–associated infection
KW - Hospital infection
KW - Limited resources countries
KW - Low-income countries
UR - https://www.scopus.com/pages/publications/85188663026
U2 - 10.1016/j.ajic.2024.02.017
DO - 10.1016/j.ajic.2024.02.017
M3 - Artículo
C2 - 38437883
AN - SCOPUS:85188663026
SN - 0196-6553
VL - 52
SP - 906
EP - 914
JO - American Journal of Infection Control
JF - American Journal of Infection Control
IS - 8
ER -